Mary Tilson is an accomplished regulatory affairs professional with over 14 years of experience. She specializes in global phase 3 clinical studies, preclinical research, and Phase 1 to Phase 4 drug development. She has extensive knowledge in therapeutic areas such as oncology, hemophilia, Parkinson's disease, and anemia due to chronic kidney disease, among others. Mary has excellent project management, writing, and communication skills, enabling her to adapt to changing business needs and regulatory environments. She holds a B.A. in Management from St. Mary's College and has held various positions, including Senior Manager and Associate Director at Exelixis and Regulatory Affairs Specialist at Acologix, Inc.